Jim Cramer’s Top 5 Stock Picks for 2022

2. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Holders: 81

AbbVie Inc. (NYSE:ABBV) makes and sells pharmaceuticals. Elite hedge funds hold large stakes in the company. At the end of the third quarter of 2021, 81 hedge funds in the database of Insider Monkey held stakes worth $4.1 billion in AbbVie Inc. (NYSE:ABBV). 

In late December, Cramer picked AbbVie Inc. (NYSE:ABBV) as one of the stocks that would go higher in the coming months primarily because of the potential its drugs offered. Cramer singled out the bright prospects of Rinvoq, an arthritis treatment, in particular, underlining that the drug would help AbbVie Inc. (NYSE:ABBV) exceed earnings expectations.